CD38/cyclic ADP-ribose system: A new player for oxytocin secretion and regulation of social behaviour

Journal of Neuroendocrinology

Volumn 22, Issue 5, 2010, Pages 380-392

  Salmina, A B ^a   Lopatina, O ^b   Ekimova, M V ^a   Mikhutkina, S V ^a   Higashida, H ^b  

^a KRASNOYARSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Autism; CD38; Cyclic ADP ribose; Oxytocin; Social behaviour

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; ESTRADIOL; GLUTAMIC ACID; NORADRENALIN; OXYTOCIN; OXYTOCIN RECEPTOR; SOMATOMEDIN C;

ARTICLE; AUTISM; AUTOREGULATION; CALCIUM SIGNALING; DEVELOPMENTAL DISORDER; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; OXYTOCIN RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SOCIAL BEHAVIOR; ANIMAL; HYPOTHALAMUS; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALS; ANTIGENS, CD38; CYCLIC ADP-RIBOSE; HYPOTHALAMUS; MICE; MICE, KNOCKOUT; OXYTOCIN; SOCIAL BEHAVIOR;

EID: 77957335557     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2010.01970.x     Document Type: Article

References (112)

1. Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997; 138: 2829-2834.
2. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
3. Carter CS. Developmental consequences of oxytocin. Physiol Behav 2003; 79: 383-397.
4. Veneema AH, Neumann ID. Central vasopressin and oxytocin release: regulation of complex social behaviors. Prog Brain Res 2008; 170: 261-276.
5. Ishunina TA, Swaab DF. Neurohypophyseal peptides in ageing and Alzheimer's disease. Ageing Res Rev 2002; 1: 537-558.
6. Chevaleyre V, Moos FC, Desarmenien MG. Correlation between electrophysiological and morphological characteristics during maturation of rat supraoptic neurons. Eur J Neurosci 2001; 13: 1136-1146.
7. Lipari EF, Lipari D, Gerbino A, Liberto DD, Bellafiore M, Catalano M, Valentino B. The hypothalamic magnocellular neurosecretory system in developing rats. Eur J Histochem 2001; 45: 163-168.
8. 2+ influx. J Neurosci 2004; 24: 1226-1235.
9. Douglas AJ, Meddle SL. Fast delivery: a central role for oxytocin. In: Bridges RS, ed. Neurobiology of the Parental Brain. Amsterdam: Elsevier, 2008: 225-234.
10. Leng G, Meddle SL, Douglas AG. Oxytocin and the maternal brain. Curr Opin Pharmacol 2008; 8: 731-734.
11. Neumann ID. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem Soc Trans 2007; 35: 1252-1257.
12. Engelmann M, Landgraf R, Wotjak CT. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004; 25: 132-149.
13. Sabatier N. Alfa-melanocyte-stimulating hormone and oxytocin: a peptide signaling cascade in the hypothalamus. J Neuroendocrinol 2006; 18: 703-710.
14. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5: 514-516.
15. Tobin VA, Ludwig M. The actin filament and dendritic peptide release. Biochem Soc Trans 2007; 35: 1243-1246.
16. Leng G, Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J Physiol 2008; 586: 5625-5632.
17. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviors. Nat Rev Neurosci 2006; 7: 126-136.
18. Ludwig M, Sabatier N, Bull PM, Landgraf R, Dayanithi G, Leng G. Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites. Nature 2002; 418: 85-89.
19. Landgraf R, Neumann ID. Neuropeptide release within the brain: a dynamic concept of multiple and variable modes of communication. Front Neuroendocrinol 2004; 25: 150-176.
20. McNally JM, De Crescenzo V, Fogarty KE, Walsh JV, Lemos J. Individual calcium syntillas do not trigger spontaneous exocytosis from nerve terminals of the neurohypophysis. J Neurosci 2009; 29: 14120-14126.
21. Ceni C, Pochon N, Brun V, Muller-Steffner Hl, Andrieux A, Grunwald D, Schuber F, De Waard M, Lund F, Villaz M, Moutin M-J. CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain. Biochem J 2003; 370: 175-183.
22. Mizuguchi M, Otsuka N, Sato M, Ishii Y, Kon S-I, Yamada M, Nishina H, Katada T, Ikeda K. Neuronal localization of CD38 antigen in the human brain. Brain Res 1995; 697: 235-240.
23. Aksoy P, White TA, Thompson M, Chini EN. Regulation of intracellular level of NAD: a novel role for CD38. Biochem Biophys Res Commun 2006; 345: 1386-1392.
24. Higashida H, Hashii M, Yokoyama S, Hoshi N, Chen X-L, Egorova A, Noda M, Zhang J-S. Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase. Pharmacol Ther 2001; 90: 283-296.
25. Salmina AB, Olovyannikova RY, Noda M, Higashida H. NAD+ metabolism and ADP-ribosyl cyclase as targets for central nervous system therapy. Curr Med Chem 2006; 6: 193-210.
26. Higashida H, Salmina AB, Olovyannikova RY, Hashii M. Cyclic ADPribose as a universal calcium signal molecule in the nervous system. Neurochem Int 2007; 51: 192-199.
27. Yamasaki-Mann M, Demuro A, Parker I. cADPR stimulates SERCA activity in Xenopus oocytes. Cell Calcium 2009; 45: 295-299.
28. Jin D, Liu H-X, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder N, Yamada K, Noda M, Salmina AB, Munesue T, Shimizu N, Mochida S, Asano M, Higashida H. CD38 is critical for social behavior by regulating oxytocin secretion. Nature 2007; 446: 41-45.
29. 2+ signals in pancreatic acinar and beta cells. J Biol Chem 2004; 279: 7234-7240.
30. Zhang B-J, Kuzano K, Zerfas P, Iacangelo A, Young WS III, Gainer H. Targeting of green fluorescent protein to secretory granules in oxytocin magnocellular neurons and its secretion from neurohypophysial nerve terminals in transgenic mice. Endocrinology 2002; 143: 1036-1046.
31. Higashida H, Jin D, Liu H-X, Lopatina O, Yokoyama S, Koizumi K, Hashii M, Islam MS, Hayashi K, Munesue T. Social memory, maternal care, and oxytocin secretion, but not vasopressin release, require CD38 in mice. In: Bridges RS, ed. Neurobiology of Parental Brain. Amsterdam: Elsevier, 2008: 361-375.
32. Kasting NW. Simultaneous and independent release of vasopressin and oxytocin in the rat. Can J Physiol Pharmacol 1988; 66: 22-26.
33. Engelmann M, Ebner K, Landgraf R, Holsboer F, Wotjak CT. Emotional stress triggers intrahypothalamic but not peripheral release of oxytocin in male rats. J Neuroendocrinol 1999; 11: 867-872.
34. Wotjak CT, Ganster J, Kohl G, Holsboer F, Landgraf R, Engelmann M. Dissociated central and peripheral release of vasopression, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998; 85: 1209-1222.
35. 2+ concentration of isolated rat supraoptic cells in response to oxytocin. J Physiol 1994; 478: 275-288.
36. Ludwig M, Bull PM, Tobin VA, Sabatier N, Landgraf R, Dayanithi G, Leng G. Regulation of activity-dependent vasopressin release from rat supraoptic neurons. J Physiol 2005; 2: 515-522.
37. Arai R, Jacobowitz DM, Hida T. Calbindin D28k and calretinin in oxytocin and vasopressin neurons of the rat supraoptic nucleus. Cell Tissue Res 1999; 298: 11-19.
38. +/cyclic ADP-ribose system. Ann NY Acad Sci 2004; 1028: 176-191.
39. 2+ homeostasis in supraoptic magnocellular neurons. Cell Calcium 2007; 41: 441-450.
40. Sladek CD, Kapoor JR. Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Exp Neurol 2001; 171: 200-209.
41. Skuse DH, Gallagher L. Dopaminergic-neuropeptide interactions in the social brain. Trends Cogn Sci 2008; 13: 27-35.
42. Durand D, Pampillo M, Caruso C, Lasaga M. Role of metabotropic glutamate receptors in the control of neuroendocrine function. Neuropharmacology 2008; 55: 577-583.
43. Pampillo M, Diaz MC, Duvilanski BH, Rettori V, Seilicovich A, Lasaga M. Differential effects of glutamate agonists and D-aspartate on oxytocin release from hypothalamus and posterior pituitary of male rats. Endocrine 2001; 15: 309-315.
44. Morsette DJ, Sidorowicz H, Sladek CD. Role of metabotropic glutamate receptors in vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol 2001; 281: R452-R458.
45. Richards DS, Villalba RM, Alvarez FJ, Sternt JE. Expression of GABAB receptors in magnocellular neurosecretory cells of male, virgin female and lactating rats. J Neuroendocrinol 2005; 17: 413-423.
46. Stern JE. Nitric oxide and homeostatic control: an intercellular signaling molecule contributing to autonomic and neuroendocrine integration. Prog Biophys Mol Biol 2004; 84: 197-215.
47. Wang S, Teschemacher AG, Paton JFR, Kasparov S. Mechanism of nitric oxide action on inhibitory GABAergic signaling within the nucleus tractus solitarii. FASEB J, 2006; 20: 1537-1539.
48. Sun M-K, Nelson TJ, Alkon DL. Functional switching of GABAergic synapses by ryanodine receptor activation. Proc Natl Acad Sci USA 2000; 97: 12300-12305.
49. Ster J, Colomer C, Monzo C, Duvoid-Guillou A, Moos F, Alonso G, Hussy N. Insulin-like growth factor-1 inhibits adult supraoptic neurons via complementary modulation of mechanoreceptors and glycine receptors. J Neurosci 2005; 25: 2267-2276.
50. Semeniken K, Merchenthaler I, Hu W, Dudas B. Catecholaminergic input to the oxytocin neurosecretory system in the human hypothalamus. J Chem Neuroanat 2009; 37: 229-233.
51. Panayotacopoulou MT, Raadsheer FC, Swaab DF. Colocalization of tyrosine hydroxylase with oxytocin or vasopressin in neurons of the human paraventricular and supraoptic nucleus. Brain Res Dev Brain Res 1994; 83: 59-66.
52. Onaka T. Neural pathways controlling central and peripheral oxytocin release during stress. J Neuroendocrinol 2004; 16: 308-312.
53. Daftary SS, Boudaba C, Szabó K, Tasker JG. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J Neurosci 1998; 18: 10619-10628.
54. Douglas AJ, Scullion S, Antonijevich IA, Brown D, Russel JA, Leng G. Uterine contractile activity stimulates supraoptic neurons in term pregnant rats via a noradrenergic pathway. Endocrinology 2001; 142: 633-644.
55. Maolood N, Grange-Messent V, Raison D, Hardin-Pouzet H. Noradrenergic stimulation in mouse supraoptic nucleus involves a nitric oxide pathway only to regulate arginine-vasopressin expression and not oxytocin expression. J Neurosci Res 2010; 85: 2991-2999.
56. Lipschitz DL, Crowley WR, Bealer SL. Differential sensitivity of intranuclear and systemic oxytocin release to central noradrenergic receptor stimulation during mid- and late gestation in rats. Am J Physiol Endocrinol Metab 2004; 287: E523-E528.
57. Shibuya I, Tanaka K, Hattori Y, Uezono Y, Harayama N, Noguchi J, Ueta Y, Izumi F, Yamashita H. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurons. J Physiol 1999; 514.2: 351-367.
58. Song Z, Gomes DA, Stevens W. Role of purinergic P2Y1 receptors in regulation of vasopressin and oxytocin secretion. Am J Physiol Regul Integr Comp Physiol 2009; 297: R478-R484.
59. Howe HE, Sonponpun SJ, Sladek CD. Role of neurokinin 3 receptors on supraoptic vasopressin and oxytocin neurons. J Neurosci 2004; 24: 10103-10110.
60. Kapoor JR, Sladek CD. Substance P and NPY differently potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol 2001; 280: R69-R78.
61. Juszczak M, Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamoneurohypophysial system: in vitro studies. Brain Res Bull 2003; 59: 393-397.
62. Gomes DA, Song Z, Stevens W, Sladek CD. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol 2009; 297: R940-R949.
63. Sperlagh B, Kittel A, Lajtha A, Vizi ES. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzyme cytochemical evidence. Neuroscience 1995; 66: 915-920.
64. Kapoor JR, Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci 2000; 20: 8868-8875.
65. 2X2 purinoceptor. J Physiol 1998; 511.1: 89-103.
66. Sperlagh B, Mergl Z, Juranyi Z, Vizi ES, Makara GB. Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis. J Endocrinol 1999; 160: 343-350.
67. Bicknell RJ, Leng G. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis. Nature 1982; 298: 161-162.
68. Maysinger D, Vermes I, Tilders F, Seizinger BR, Gramsch C, Höllt V, Herz A. Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro. Naunyn Schmiedeberg's Arch Pharmacol 1984; 328: 191-195.
69. Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation. Endocrinology 1986; 119: 1-11.
70. + currents in magnocellular neurons of the supraoptic nucleus in rat. J Neurophysiol 1999; 81: 1617-1625.
71. Coiro V, Chiodera P. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man. Neuroendocrinology 1991; 53: 209-213.
72. Tasker J. Endogenous cannabioids take the edge off neuroendocrine responses to stress. Endocrinology 2004; 145: 5429-5430.
73. Crowley WR, Shyr S-W, Kacsoh B, Grosvenor CE. Evidence for stimulatory noradrenergic and inhibitory dopaminergic regulation of oxytocin release in the lactating rat. Endocrinology 1997; 121: 14-20.
74. Azdad D, Piet R, Poulain DA, Oliet SHR. Dopamine D4 receptor-mediated inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 2003; 90: 559-565.
75. Bealer SL, Crowley WR. Stimulation of central and systemic oxytocin release by histamine in the paraventricular hypothalamic nucleus: evidence for an interaction with norepinephrine. Endocrinology 1999; 140: 1158-1164.
76. Sheikh SP, Feldthus N, Orkild H, Goke R, McGregor GP, Turner D, Moller M, Stuenkel EL. Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin release. Neuroscience 1997; 81: 107-115.
77. Morris JF, Christian H, Ma D, Wang H. Dendritic secretion of peptides from hypothalamic magnocellular neurosecretory neurones: a local dynamic control system and its functions. Exp Physiol 2000; 85: 131S-138S.
78. Somponpun S, Sladek CD. Role of estrogen receptor-b in regulation of vasopressin and oxytocin release in vitro. Endocrinology 2002; 143: 2899-2904.
79. Theodosis DT, Trailin A, Poulain DA. Remodeling of astrocytes, a prerequisite for synapse turnover in the adult brain? Insights from the oxytocin system of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1175-R1182.
80. Choleris E, Gustafsson J-A, Korach KS, Muglia LJ, Pfaff DW, Ogawa S. An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-a and -b knockout mice. Proc Natl Acad Sci USA 2003; 100: 6192-6197.
81. Mani SK, Portillo W, Reyna A. Steroid hormone action in the brain: cross-talk between signaling pathways. J Neuroendocrinol 2009; 21: 243-247.
82. Liu H-X, Lopatina O, Higashida C, Tsuji T, Kato I, Takasawa S, Okamoto H, Yokoyama S, Higashida H. Locomotor activity, ultrasonic vocalization and oxytocin levels in infant CD38 knockout mice. Neurosci Lett 2008; 448: 67-70.
83. 2+ - concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice. Neuropharmacology 2010; 58: 50-55.
84. Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Minton SK, Taves SR, Casper KB, Fiacco TA, McCarthy KD. What is the role of astrocyte calcium in neurophysiology? Neuron 2008; 59: 932-946.
85. Hatton GI. Morphological plasticity of astroglial/neuronal interactions: functional implications. In: Hatton GI, Parpura V, eds. Glial Neuronal Signaling. Boston, MA: Kluwer Academic, 2004: 99-124.
86. Salm AK. Mechanisms of glial retraction in the hypothalamo-neurohypophysial system of the rat. Exp Physiol 2000; 85S: 197S-202S.
87. Wang Y-F, Hatton GI. Astrocytic plasticity and patterned oxytocin neuronal activity: dynamic interactions. J Neurosci 2009; 29: 1743-1754.
88. Theodosis DT, Montagnese C, Rodriguez F, Vincent JD, Poulain DA. Oxytocin induces morphological plasticity in the adult hypothalamoneurohypophysial system. Nature 1986; 322: 738-740.
89. Malarkey EB, Parpura V. Mechanisms of transmitter release from astrocytes. In. Parpura V, Haydon PG, eds. Astrocytes in the Pathophysiology of the Nervous System. Springer, New York, USA: 2009: 301-350.
90. Parpura V, Haydon PG. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA 2000; 97: 8629-8634.
91. Bergesen LH, Gundersen V. Morphological evidence for vesicular glutamate release from astrocytes. Neuroscience 2009; 158: 260-265.
92. 2+ - dependent glutamate release. Neuroscience 2009; 158: 253-259.
93. Verderio C, Bruzzone S, Zocchi E, Fedele E, Schenk U, De Flora A, Matteoli MJ. Evidence of a role for cyclic ADP-ribose in calcium signaling and neurotransmitter release in cultured astrocytes. J Neurochem 2001; 78: 1-13.
94. Bruzzone S, Verderio C, Schenk U, Fedele E, Zocchi E, Matteoli M, De Flora A. Glutamate-mediated overexpression of CD38 in astrocytes cultured with neurons. J Neurochem 2004; 89: 264-272.
95. Eisner I, Colombo JA. Detection of a novel pattern of connexin 43 immunoreactivity responsive to dehydration in rat hypothalamic magnocellular nuclei. Exp Neurol 2002; 177: 321-325.
96. Ye Z-C, Wyeth MS, Baltan-Tekkok S, Ransom BR. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 2003; 23: 3588-3596.
97. Nakase T, Naus CC. Gap junctions and neurological disorders of the central nervous system. Biochim Biophys Acta 2004; 1662: 149-158.
98. + and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem 2001; 276: 21642-21648.
99. 2+ signaling in astrocytes in situ. J Biol Chem 2005; 280: 35630-35640.
100. Pawlikowska L, Votrell SE, Harms MB, Li Y, Rosenberg PA. Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture. J Neurosci 1996; 16: 5372-5381.
101. Neumann ID. Oxytocin: the neuropeptide of love reveals some of its secrets. Cell Metab 2007; 5: 231-233.
102. Young LJ. Regulating the social brain: a new role for CD38. Neuron 2007; 54: 353-356.
103. Neumann ID. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol 2008; 20: 858-865.
104. Heinrichs M, von Dawans B, Domes G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 2009; 30: 548-557.
105. Carter CS, Boone EM, Pournajafi-Nazarloo H, Bales KL. Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic. Dev Neurosci 2009; 31: 332-341.
106. MacDonald K, MacDonald TM. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 2010; 18: 1-21.
107. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113: e472-e486.
108. Soorya L, Kiarashi J, Hollander E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 2008; 17: 753-771.
109. Krey JF, Dolmetsch RE. Molecular mechanisms of autism: a possible role for calcium signaling. Curr Opin Neurobiol 2007; 17: 112-119.
110. Batz JA, McInnes LA. CD38 regulates oxytocin secretion and complex social behavior. Bioessays 2007; 29: 837-841.
111. 2+ -mobilizing second messenger. Structure-activity relationship of the N1-ribose moiety. J Am Chem Soc 2005; 127: 8846-8855.
112. Deaglio S, Aydin S, Vaisitti T, Bergui L, Malavasi F. CD38 at the junction between prognostic marker and therapeutic target. Trends Mol Med 2008; 14: 210-218.